INSTITUTE OF BIOMED RESH (MRES) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 134 197 sessions, September 10, 2025 to September 11, 2026
- Largest daily move
- +85.7% close of January 22, 2026
- 1-year change
- -57.4% closing prices, September 10, 2025 to September 11, 2026
- 5-year change
- -85.5% closing prices, September 10, 2021 to September 11, 2026
Company Description
INSTITUTE OF BIOMED RESH (OTC: MRES) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $18.4M.
MRES has declined 57.4% over the past year. The last closing price was $0.0029.
This page collects what Stock Titan holds for MRES, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
INSTITUTE OF BIOMED RESH (MRES) closed at $0.0029 on September 11, 2026. Over the past 12 months, the price has lost 57.4%.
MRES Metrics & Rankings
Price returns through September 11, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
INSTITUTE OF BIOMED RESH has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 6 with negative movement. Key topics include acquisition. View all MRES news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in INSTITUTE OF BIOMED RESH (MRES) currently stands at 304.5 thousand shares, a new position with no short interest reported in the previous period, representing 0.0% of the float. Since September 2025, short interest has increased by 384.9%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for INSTITUTE OF BIOMED RESH (MRES) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
MRES Company Profile & Sector Positioning
INSTITUTE OF BIOMED RESH (MRES) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing MRES often look at related companies in the same sector, including RAPID DOSE THERAPEUTICS (RDTCF), FINCH THERAPEUTCS GRP INC (FNCH), BIOMIND LABS INC (BMNDF), PHARMATHER HLDGS LTD (PHRRF), and ONCOTELIC THERAPEUTCS INC (OTLC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MRES's relative position within its industry.